| 期刊論文| 1. | Dunner, D. L.、Rush, A. J.、Russell, J. M.、Woodward, S.、Wingard, P.、Allen, J.(2006)。Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression。J Clin Psychiatry，67，688-695。   | | 2. | Price, L. H.、Charney, D. S.、Heninger, G. R.(1986)。Variability of response to lithium augmentation in refractory depression。Am J Psychiatry，143，1387-1392。 | | 3. | Berman, R. M.、Marcus, R. N.、Swanink, R.(2007)。The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo controlled study。J Clin Psychiatry，68，843-853。 | | 4. | Berman, R. M.、Fava, M.、Thase, M. E.(2009)。Aripiprazole augmentation in major depressive disorder: a doubleblind, placebo-controlled study in patients with inadequate response to antidepressants。CNS Spectr，14，197-206。 | | 5. | Chiu, Y. H.、Lee, T. H.、Shen, W. W.(2007)。Use of low-dose topiramate in substance use disorder and bodyweight control。Psychiatry and Clinical Neurosciences，61(6)，630-633。 | | 6. | Marcus, R. N.、McQuade, R. D.、Carson, W. H.(2008)。The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study。J Clin Psychopharmacol，28，156-165。 | | 7. | Shen, Winston W.(2016)。Antidepressant therapy。Aino Journal，15，1-13。 | | 8. | Keller, M. B.、Klerman, G. L.、Lavori, P. W.(1984)。Longterm outcome of episodes of major depression: clinical and public health significance。JAMA，252，788-792。 | | 9. | Mojtabai, R.(2017)。Nonremission and time to remission among remitters in major depressive disorder: revisiting STAR*D。Depress Anxiety，34，1123-1133。 | | 10. | Dunner, David L.(20130600)。Treatment-resistant Depression。Taiwanese Journal of Psychiatry，27(2)，110-120。 | | 11. | Rush, A. John、Trivedi, Madhukar H.、Wisniewski, Stephen R.、Nierenberg, Andrew A.、Stewart, Jonathan W.、Warden, Diane、Niederehe, George、Thase, Michael E.、Lavori, Philip W.、Lebowitz, Barry D.、McGrath, Patrick J.、Rosenbaum, Jerrold F.、Sackeim, Harold A.、Kupfer, David J.、Luther, James、Fava, Maurizio(2006)。Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report。American Journal of Psychiatry，163(11)，1905-1917。 | | 12. | Sinyor, M.、Schaffer, A.、Levitt, A.(2010)。The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Trial: a review。Can J Psychiatry，55，126-135。 | | 13. | Zimmerman, M.、McGlinchey, J. B.、Posternak, M. A.、Friedman, M.、Attiullah, N.、Boerescu, D.(2006)。How should remission from depression be defined? the depressed patient,s perspective。Am J Psychiatry，163，148-150。 | | 14. | Healy, D.、McMonagle, T.(1997)。The enhancement of social functioning as a therapeutic principle in the management of depression。J Psychopharmacol，11(supp 4)，S25-S31。 | | 15. | Lopez-Ibor, J.、Guelfi, J. D.、Pletan, Y.、Tournoux, A.、Prost, J. F.(1996)。Milnacipran and selective serotonin reuptake inhibitors in major depression。Int Clin Psychopharmacol，11(Suppl 4)，S41-S46。 | | 16. | Thase, M. E.、Entsuah, A. R.、Rudolph, R. L.(2001)。Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors。Br J Psychiatry，178，234-241。 | | 17. | Thase, M. E.、Pritchett, Y. L.、Ossanna, M. J.、Swindle, R. W.、Xu, J.、Detke, M. J.(2007)。Effi cacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder。J Clin Psychopharmacol，27，672-676。 | | 18. | Thase, M. E.、Nierenberg, A. A.、Vrijland, P.、Van Oers, H. J.、Schutte, A. J.、Simmons, J. H.(2010)。Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression。Int Clin Psychopharmacol，25，189-198。 | | 19. | Nierenberg, A. A.、Keefe, B. R.、Leslie, V. C.(1999)。Residual symptoms in depressed patients who respond acutely to fluoxetine。J Clin Psychiatry，60，221-225。 | | 20. | Brecht, S.、Desaiah, D.、Elisete, S.、Marechal, E. S.(2011)。Effi cacy and safety of duloxetine 60 mg and 120 mg daily in patients hospitalized for severe depression: a double-blind randomized trial。J Clin Psychiatry，72，1086-1109。 | | 21. | Koponen, H.、Allgulander, C.、Erickson, J.(2007)。Effi cacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians。Prim Care Companion J Clin Psychiatry，9，100-107。 | | 22. | McGrath, P. J. l.、Stewart, J. W.、Fava, M.(2006)。Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report。Am J Psychiatry 2006，163，1531-1541。 | | 23. | Stahl, S. M.(2014)。Mechanism of action of agomelatine: a novel antidepressant exploiting synergy between monoaminergic and melatonergic properties。CNS Spectr，19，207-212。 | | 24. | Eison, A. S.(1990)。Azapirones: history of development。J Clin Psychopharmacol，10(Suppl 3)，2S-5S。 | | 25. | Warren, C. R.、Serrato, J. J.、Maguire, G. A.(2012)。Off-lebel uses of second-generation antipsychotic drugs。Taiwanese Journal of Psychiatry，26，162-176。 | | 26. | Nelson, J. C.、Andrei, Pikalov A.、Berman, R. M.(2008)。Augmentation treatment in major depressive disorder: focus on aripiprazole。Neuropsychiatr Dis Treat，4，937-948。 | | 27. | Nelson, J. C.、Papakostas, G. I.(2009)。Atypical antipsychotic augmentation in major depressive disorder: a metaanalysis of placebo-controlled randomized trials。Am J Psychiatry，166，980-991。 | | 28. | Corya, S. A.、Williamson, D.、Sanger, T. M.、Briggs, S. D.、Case, M.、Tollefson, G.(2006)。A randomized, double-blind comparison of olanzapine/fl uoxetine combination, olanzapine, fl uoxetine, and venlafaxine in treatmentresistant depression。Depress Anxiety，23，364-372。 | | 29. | Shelton, R. C.、Tollefson, G. D.、Tohen, M.(2001)。A novel augmentation strategy for treating resistant major depression。Am J Psychiatry，158，131-134。 | | 30. | Dorée, J. P.、Des Rosiers, J.、Lew, V.(2007)。Quetiapine augmentation of treatment-resistant depression: a comparison with lithium。Curr Med Res Opin，23，333-341。 | | 31. | El-Khalili, N.、Joyce, M.、Atkinson, S.(2010)。Extendedrelease quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study。Int J Neuropsychopharmacol，13，917-932。 | | 32. | López-Muñoz, F.、Shen, W. W.、D'Ocon, Pilar、Romero, A.、Álamo, C.(2018)。A history of the pharmacological treatment of bipolar disorder。International Journal of Molecular Sciences，19(7)。 | | 33. | Bschor, T.、Lewitzka, U.、Sasse, J.、Adli, M.、Köberle, U.、Bauer, M.(2003)。Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms。Pharmacopsychiatry，36(suppl 3)，S230-S234。 | | 34. | Sugawara, H.、Sakamoto, K.、Harada, T.、Ishigooka, J.(2010)。Predictors of effi cacy in lithium augmentation for treatment-resistant depression。J Affect Disord，125，165-168。 | | 35. | Nierenberg, A. A.、Fava, M.、Trivedi, M. H.(2006)。A comparison of lithium and T3 augmentation following two failed medication treatments for depression: a STAR*D report。Am J Psychiatry，163，1519-1530。 | | 36. | Cooper-Kazaz, R.、Lerer, B.(2008)。Effi cacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specifi c serotonin reuptake inhibitors。Int J Neuropsychopharmacol，11，685-699。 | | 37. | Agid, O.、Lerer, B.(2003)。Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specifi c serotonin reuptake inhibitor and to triiodothyronine augmentation。Int J Neuropsychopharmacol，6，41-49。 | | 38. | Shiroma, P. R.、Johns, B.、Kuskowski, M.(2014)。Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression。J Affect Disord，155，123-129。 | | 39. | Hartberg, J.、Garrett-Walcott, S.、De Gioannis, A.(2018)。Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study。Psychopharmacology，235，393-398。 | | 40. | Shen, W. W.(2018)。Anticraving therapy for alcohol use disorder: a clinical review。Neuropsychopharmacology Reports，38，105-116。 | | 41. | Kessler, R. C.、Berglund, P.、Demler, O.、Jin, R.、Koretz, D.、Merikangas, K. R.、Rush, A. J.、Walters, E. E.、Wang, P. S.(2003)。The Epidemiology of Major Depressive Disorder: Results from the National Comorbidity Survey Replication (NCS-R)。Journal of the American Medical Association，289，3095-3105。 | 圖書| 1. | Shen, W. W.(2011)。Clinical Psychopharmacology for the 21st Century。Taipei：Hochi Publishing Company。 | | 2. | American Psychiatric Association(2013)。Diagnostic and statistical manual of mental disorder。Washington, DC：American Psychiatry Association。 | | 3. | American Psychiatric Association(2010)。Practice Guideline for the Treatment of Patients with Major Depressive Disorder。American Psychiatric Association。 | |